Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Genprex, Inc.

NASDAQ: GNPX · Life Sciences · 5 alerts · CIK 1595248

Share price
$1.90Close, Nov 16
Market cap
$2.54M
Shares outstanding
1.33MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Genprex, Inc. filings on SEC EDGAR ↗

4:18 PM ET 10-Q
Financial Results

Genprex Q3 2026 Results: Net Loss of $4.24M, Loss Widens

Genprex, Inc. reported a net loss of $13.1 million for the nine months ended September 30, 2026, compared to $12.4 million in the prior year period. The company significantly strengthened its cash position to $15.3 million through $18.7 million in net proceeds from common stock issuances, supporting its ongoing clinical development of gene therapies for oncology and diabetes.

Key figure
Net loss $4.24M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.